Why the study?
Does cilazapril lower blood pressure and suppress plasma ACE levels in hypertensive patients?
Does cilazapril lower blood pressure and suppress plasma ACE levels in hypertensive patients?
Cilazapril at 5-10 mg daily provides maximal acute blood pressure lowering and ACE suppression in hypertensive patients.
Answers are grounded in this paper and cite their sources.
Supports cilazapril dosing exploration in hypertension; extends pharmacokinetic data but leaves open efficacy pending randomized trials.
This study assesses the magnitude and duration of action of three different oral doses of the new orally active angiotensin-converting enzyme (ACE) inhibitor RO 312848 (cilazapril, Hoffman-LaRoche, Nutley, NJ) on blood pressure and plasma ACE levels. Twelve hypertensive patients were separated into two groups: Group A (n = 6) received two single daily doses of 5 and 10 mg, each preceded and followed by two placebo days, and Group B (n = 6) received 10 and 20 mg on an identical protocol. The onset and duration of an appreciable blood pressure lowering effects were at 2 hours and at least for 12 hours, respectively, whereas suppression of ACE levels occurred at 1 hour and lasted for more than 72 hours. Response of these two parameters was partial after 5 mg, but was maximal after 10 mg and did not increase further with the 20-mg dose. A 5-10 mg dose daily may be sufficient to maintain chronic blood pressure control with this agent, but long-term dose trials are necessary to establish its clinical utility.
No takes yet. Share an insight, caveat, or question.
Mulinari et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: